I
ANIP icon

InceptionR’s ANI Pharmaceuticals ANIP Stock Holding History

InceptionR’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$471K Buy
+5,693
New +$457K 0.12% 326
2026
Q1 		– Sell
-3,143
Closed -$248K – 645
2025
Q4 		$248K Buy
+3,143
New +$272K 0.07% 482

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

InceptionR's ANIP Position: Q2 2026 in Review

InceptionR opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2026: 5,693 shares worth $471K. The stake represents 0.12% of the portfolio and ranks #326 among its holdings. This is a return to the name: InceptionR previously reported a position in ANIP as recently as Q4 2025.

InceptionR first reported a position in ANIP in Q4 2025 and has held it in 2 quarters since. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • InceptionR held 5,693 shares of ANI Pharmaceuticals worth $471K as of Q2 2026.
  • ANI Pharmaceuticals was a new InceptionR position in Q2 2026.
  • ANI Pharmaceuticals made up 0.12% of InceptionR's portfolio in Q2 2026, its #326 holding.
  • InceptionR first reported a position in ANI Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.